Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrrolate pMDI add-on to Qvar in uncontrolled asthma
NL-OMON41903Phase 2Active, not recruiting
- Sponsor
- CROMSOURCE
- Start
- Nov 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of beclomethasone and glycopyrronium in asthma (2 arms), sponsored by CROMSOURCE. Primary endpoint: FEV1 AUC0-12h normalised by time on Day 42. Started Nov 2014; status: active, not recruiting.
02
Drugs
beclomethasoneglycopyrronium
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON41903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41903.